Monday, November 16, 2020 10:38:44 AM
Keep an eye on L2
They dont know what to do with us right now.
They keep flipping to all 1s on the bid/ask.
Little to no volume.
People are holding.
One nice large buy would cause some interesting reaction.
They dont know what to do with us right now.
They keep flipping to all 1s on the bid/ask.
Little to no volume.
People are holding.
One nice large buy would cause some interesting reaction.
Never buy or sell based on my posts.Always consult with a licensed securities professional before you buy or sell any security.My posts are opinions only.Never use them as due diligence.My positions are subject to change without notice.
Recent CAPR News
- Form ARS - Annual Report to Security Holders • Edgar (US Regulatory) • 04/10/2026 09:17:53 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 04/10/2026 08:31:03 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/03/2026 09:00:07 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 04/02/2026 08:24:33 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/02/2026 12:00:15 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/02/2026 12:00:12 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/02/2026 12:00:11 AM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 03/31/2026 09:24:08 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/31/2026 08:23:33 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/31/2026 08:23:03 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/31/2026 08:22:42 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/27/2026 11:15:05 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 03/17/2026 09:00:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/12/2026 08:01:07 PM
- Capricor Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Update • GlobeNewswire Inc. • 03/12/2026 08:01:00 PM
- Capricor Therapeutics Announces Late-Breaking HOPE-3 Data at the 2026 MDA Conference Demonstrating Significant Functional Benefits of Deramiocel for Duchenne Muscular Dystrophy • GlobeNewswire Inc. • 03/12/2026 01:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/10/2026 03:01:36 PM
- Capricor Therapeutics Announces Establishment of New PDUFA Date for Deramiocel BLA • GlobeNewswire Inc. • 03/10/2026 01:25:00 PM
- Capricor Therapeutics to Present Fourth Quarter and Full Year 2025 Financial Results and Recent Corporate Update on March 12 • GlobeNewswire Inc. • 03/09/2026 12:30:00 PM
- Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors • Edgar (US Regulatory) • 02/27/2026 12:10:54 AM
- Capricor Therapeutics Announces Late-Breaking Presentation at 2026 MDA Clinical and Scientific Conference • GlobeNewswire Inc. • 02/24/2026 02:00:00 PM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 01/30/2026 10:01:12 PM
- Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors • Edgar (US Regulatory) • 01/26/2026 09:15:18 PM
- Capricor Therapeutics Provides Regulatory Update on Deramiocel BLA Following FDA Review of HOPE-3 Topline Data • GlobeNewswire Inc. • 01/20/2026 02:15:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/07/2026 09:45:17 PM
